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Abstract The Ser^Thr kinase Akt is activated in epithelial cells
by Salmonella enterica serovar typhimurium. The bacterial
effector SigD, which is translocated into host cells via the
specialized type III secretion system, is essential for Akt
activation. Here, we investigated the inositol phospholipid
substrate preferences of SigD. Recombinant SigD preferentially
dephosphorylated phosphatidylinositol 3,5-biphosphate and phos-
phatidylinositol 3,4,5-triphosphate over other phosphatidylinosi-
tol lipids. Phosphatidylinositol 3-phosphate was not a substrate,
suggesting the 5P phosphate moiety is one of the preferred
substrates. Database searches revealed that SigD bears a small
region of homology to the mammalian type II inositol 5-phos-
phatase synaptojanin. Mutation of two conserved residues in this
region, Lys527 and Lys530, decreased or abrogated phosphatase
activity, respectively. The Shigella flexneri SigD homologue,
IpgD, displayed a similar activity in vitro and also activated Akt
when used to complement a vsigD Salmonella strain. A mutation
in IpgD at Lys507, analogous to Lys530 of SigD, also failed to
activate Akt. Thus, we have characterized a region near the
carboxyl-terminus of SigD which is important for phosphatase
activity. We discuss how dephosphorylation of inositol phospho-
lipids by SigD in vivo might contribute to the activation of
Akt. ß 2001 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
The facultative intracellular pathogen Salmonella enterica
serovar typhimurium (S. typhimurium) is an important causa-
tive agent of food-borne gastroenteritis in humans. The ability
to breach the intestinal barrier and to survive within a variety
of mammalian cell types is required for pathogenicity and is
dependent on multiple virulence factors. Many of the genes
encoding these factors are located on the bacterial chromo-
some within ¢ve distinct Salmonella pathogenicity islands
(SPIs) (reviewed in [1]). SPI1 encodes a type III secretion
system (TTSS), which translocates e¡ectors directly into the
cytoplasm of host cells and is essential for invasion of non-
phagocytic cells [2]. These bacterial e¡ectors interact with and
alter components of eukaryotic signaling pathways and the
actin cytoskeleton, resulting in membrane ru¥ing on the cell
surface followed by bacterial internalization (Fig. 1A) [3^5].
Phosphoinositide 3-kinases (PI3Ks) are activated by a vari-
ety of extracellular signals to generate speci¢c inositol lipids
that are involved in multiple cellular activities, including the
regulation of cell growth, proliferation, survival and cytoskel-
etal changes (reviewed in [6]). One of the best-characterized
targets of PI3K lipid products is the Ser^Thr kinase Akt (also
known as PKBK). Upon cellular stimulation, Akt is recruited
from the cytosol in an inactive conformation to cellular mem-
branes by interaction of its pleckstrin homology domain with
the PI3K lipid products phosphatidylinositol 3,4,5-triphos-
phate (PtdIns(3,4,5)P3) and phosphatidylinositol 3,4-biphos-
phate (PtdIns(3,4)P2) [7]. Akt activity is not stimulated by
translocation itself but is dependent upon phosphorylation
at two residues (Thr308 and Ser473). Thr308 is phosphorylat-
ed by the phosphoinositide-dependent kinase 1, which also
contains a pleckstrin homology domain, and may also target
Akt to the membrane [8^10]. The mechanism of phosphory-
lation of Ser473 remains elusive. Possible candidates are the
integrin-linked kinase, phosphoinositide-dependent kinase 1 in
a complex with a fragment derived from protein kinase C-
related kinase 2, and Akt autophosphorylation [11^13]. It is
likely a combination of these mechanisms is at play, depend-
ing on the local membrane environment and the cell type.
Our previous work showed that S. typhimurium activates
Akt and that this activation is absolutely dependent on the
SPI1-secreted e¡ector SigD (also known as SopB) [14] (Fig.
1A). SigD dephosphorylates a variety of soluble inositol poly-
phosphates as well as inositol phospholipids in vitro, and has
been shown to convert inositol 1,3,4,5,6-pentakisphosphate
(Ins(1,3,4,5,6)P5) into inositol 1,4,5,6-tetrakisphosphate (Ins-
(1,4,5,6)P4) in vivo [15^17] (Fig. 1A). Shigella £exneri con-
tains a TTSS homologous to the SPI1 TTSS of Salmonella
and a sigD homologue, ipgD. SigD and IpgD both contain
two motifs similar to those found in mammalian inositol 4-
phosphatases. A conserved cysteine residue in the second mo-
tif is essential for the activity of mammalian inositol 4-phos-
phatases, as well as the in vitro phosphatase activity of SigD
and activation of Akt by SigD [14,17]. Intriguingly, SigD is
0014-5793 / 01 / $20.00 ß 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 3 5 6 - 0
*Corresponding author. Fax: (1)-604-822 9830.
E-mail: b¢nlay@interchange.ubc.ca
Abbreviations: PKBK, serine^threonine kinase Akt; PI3K, phospha-
tidylinositol 3-kinase; PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-tri-
phosphate; PtdIns(3,4)P2, phosphatidylinositol 3,4-biphosphate;
PtdIns(4,5)P2, phosphatidylinositol 4,5-biphosphate; PtdIns(3,5)P2,
phosphatidylinositol 3,5-biphosphate; Ins(1,3,4,5)P4, inositol 1,3,4,5-
tetrakisphosphate; Ins(1,3,4,5,6)P5, inositol 1,3,4,5,6-pentakisphos-
phate; TTSS, type III secretion system; SPI, Salmonella pathogenicity
island; PBS, phosphate-bu¡ered saline; TBS, Tris-bu¡ered saline
FEBS 24788 9-4-01
FEBS 24788 FEBS Letters 494 (2001) 201^207
not required for Salmonella-induced membrane translocation
of Akt, revealing a novel pathway in which the membrane
translocation of Akt does not lead to its activation unless
an exogenous bacterial protein is present. The mechanism
through which SigD activates Akt is unknown, prompting
us to investigate the inositol phospholipid substrate preferen-
ces of SigD.
A sequence database search against SigD revealed that it
also contains a small region of homology to the type II ino-
sitol 5-phosphatase synaptojanin located within a region
downstream of the inositol 4-phosphatase motifs (Fig. 1B).
Mammalian type II 5-phosphatases hydrolyze water-soluble
substrates such as inositol 1,4,5-triphosphate and Ins-
(1,3,4,5)P4, as well as phosphatidylinositol 4,5-biphosphate
(PtdIns(4,5)P2) and PtdIns(3,4,5)P3. We show here that re-
combinant SigD and IpgD both dephosphorylate several ino-
sitol phospholipids, and mutation of conserved lysine residues
in SigD leads to a gradual reduction in catalytic activity.
Moreover, this reduced phosphatase activity correlates with
a reduced ability of SigD to activate Akt in vivo. These stud-
ies reveal a previously uncharacterized region of SigD and
synaptojanin, which, at least for SigD, is important for phos-
phatase activity.
2. Materials and methods
2.1. Cell culture and bacterial strains
HeLa cells, S. typhimurium SL1344 wild type and the vsigD mutant
were as described previously [14,18].
2.2. Plasmid construction and protein puri¢cation
pACDE, which encodes both SigD and its chaperone SigE, was
constructed by ampli¢cation of the sigDE promoter and operon start-
ing at position 3416 with Pfu DNA polymerase (Stratagene) using the
primers D1 (5P-GCG AAT TCT ATC TGT TCA AGC ATG-3P) and
D6 (5P-CGT GAA TTC TCA TTA AGA AAG TAT GTT G) and
inserting into pCRTOPO2.1 (Invitrogen). The resulting plasmid was
digested with XhoI and HindIII and inserted into the SalI/HindIII
sites of pACYC184 (New England Biolabs). SigD point mutants
K527A and V528A were constructed by site-directed mutagenesis us-
ing SM9 (5P-GGC GGG GCG GGA AAC gca GTA ATG AAA
AAT TTA TCG CCA G-3P) and SM10 (5P-CGG GGC GGG AAA
CAA Agc aAT GAA AAA TTT A-3P), respectively, and the Sculptor
Mutagenesis kit (Amersham). To construct the SigD point mutant
L508A, two DNA fragments were ampli¢ed with Pfu DNA polymer-
ase using the primer pairs D1 (see above) with SM12 (5P-ATT CAG
tgc TAC TTT TTG GAA AAT TTT CTG TCC-3P) and D6 (see
above) with SM13 (5P-CAA AAA GTA gca CTG AAT AGC GGT
AAC CTG G-3P). The two fragments were isolated, mixed, and used
as a template in a PCR reaction with D1 and D6. The resulting DNA
was digested with KpnI and StuI, and the fragment containing the
mutation was inserted into the corresponding sites of pACDE. The
SigD point mutants, L539A and K530A, were constructed similarly.
The primers for the ¢rst ampli¢cation used with D1 were SM14 (5P-
GAT AGG AAG CAT TGA GCA CCT CTG GCG-3P) and SM019
(5P-GAT AAA TTt gcC ATT ACT TTG TTT CCC GCC C-3P),
respectively. The primers for the second ampli¢cation used with D6
were SM15 (5P-TGC TCA ATg ctT CCT ATC AAA AAC GAG
TTG-3P) and SM020 (5P-AAC AAA GTA ATG gca AAT TTA
TCG CCA GAG GTG C-3P), respectively.
To construct the pACipgDE complementing plasmid, the sigD pro-
moter, including the ribosome binding site, from position 3416 to 39
relative to the initiating ATG was ampli¢ed with Pfu DNA polymer-
ase using the primers SM4 (5P-CCG TAG ATA TCG CGA ATT
CTA TCT GTT CAA GC-3P) and SM5 (5P-GTA CGG GAT CCT
AAT ATT CCT GAA TAG GGG GA-3P) and inserted as an EcoRV^
BamHI fragment into the corresponding sites of pACYC184 to gen-
erate pSigD-400. The S. £exneri ipgD and ipgE open reading frames
from position 32 relative to the initiating ipgD ATG codon to the
ipgE stop codon were similarly ampli¢ed using the primers SM6 (5P-
ACT GGA TCC AAA TGC ACA TAA CTA ATT TGG-3P) and
SM7 (5P-ACT GTC GAC ATT AAT ACC CCT TCA TTC-3P) and
inserted as a BamHI/SalI fragment into pSigD-400.
pACipgDE* containing a C439S mutation was constructed as fol-
lows: two DNA fragments were ampli¢ed with Pfu DNA polymerase
using the primer pairs SM7 with ipgC439f (5P-CTG GAA TTC GAA
GAG TGG GAA GGA CAG AAC-3P), and SM6 with ipgC439r (5P-
TTC GAA TTC CAG CAA GGTACA GCA CC-3P). The two DNA
fragments were isolated, mixed, and used as a template in a PCR
reaction with primers SM6 and SM7. The mutated ipgD was inserted
as a BamHI/SalI fragment into pSigD-400.
For protein puri¢cation, sigD missing the ¢rst 29 codons was am-
pli¢ed with Pfu DNA polymerase using SM018 (5P-AAC GCT AGC
CAG ATT CTC TCA GGC CAG GGC-3P) and LK032 (5P-CGC
GGA TCC TCA AGA TGT GAT TAA TGA AGA-3P). The result-
ing DNA was inserted as a NheI/BamHI fragment into pET28a (No-
vagen), which generates polyhistidine tagged SigD. The ipgDE operon
was similarly ampli¢ed and inserted in pET28a using SM032 (5P-CCA
CGC GCT AGC ATG CAC ATA ACT AAT TTG GGA-3P) and
SM033 (5P-CCA CGC GGA TCC TTA ATA CCC CTT CAT TCT
TCG-3P). Fusion proteins were a⁄nity-puri¢ed on nickel-NTA aga-
rose (Qiagen) according to the manufacturer’s instructions.
2.3. Phosphoinositide phosphatase assay
Phosphoinositide phosphatase activity was measured using a chro-
mogenic assay based on the malachite green method previously used
for the analysis of protein phosphatases [19,20]. Brie£y, recombinant
puri¢ed protein (50^100 ng) was incubated with synthetic short chain
(octanoyl) phosphoinositides (Echelon Research Laboratories, Salt
Lake City, UT, USA) (50^100 WM) as indicated (temperature
T = 37‡C, reaction volume V = 25 Wl). The reactions were stopped by
addition of 80 Wl malachite green reagent [20] and absorbance mea-
sured at 620 nm. The assay provided linear detection in the range of
up to 1000 pmol of Pi.
2.4. Bacterial infection of eukaryotic cells
Bacterial infections were carried out as described previously [14].
Brie£y, bacteria were grown in Luria^Bertani broth at 37‡C to late log
phase. The culture was centrifuged at 10 000Ug for 2 min at room
temperature and resuspended in phosphate-bu¡ered saline (PBS). In-
vasion was initiated by addition of 30 Wl bacteria directly to cultured
cells. Cells were then incubated at 37‡C in 5% CO2 for 25 min, and
free bacteria were removed by washing with PBS.
2.5. Akt kinase assay
Materials for the Akt kinase assay were obtained as part of a kit
(New England Biolabs), and used according to the manufacturer’s
instructions. Brie£y, cells were lysed by the addition of 200 Wl cold
lysis bu¡er (20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
glycerolphosphate, 1 mM Na3VO4, 1 Wg/ml leupeptin), and trans-
ferred to microfuge tubes. Insoluble material was pelleted by centri-
fuging for 10 min at 16 000Ug. Total Akt was immunoprecipitated
from lysates with 20 Wl of immobilized Akt 1G1 monoclonal anti-
body. The antibody^resin was pelleted, washed twice in 1 ml lysis
bu¡er, and twice in 1 ml kinase bu¡er (25 mM Tris (pH 7.5), 5 mM
L-glycerolphosphate, 2 mM dithiothreitol (DTT), 0.1 mM Na3VO4,
10 mM MgCl2). For the kinase reaction, pellets were resuspended in
kinase bu¡er supplemented with 200 WM ATP and 1 Wg GSK-3 fusion
protein, and incubated for 30 min at 30‡C. Proteins were electropho-
resed on a standard 12% SDS^PAGE gel, transferred to nitrocellulose
membrane, and immunoblotted as described below.
2.6. Immunoblotting
Immunoblotting was performed as described [14]. Brie£y, cell ex-
tracts were prepared by adding 80 Wl of hot SDS sample bu¡er con-
taining 50 mM DTT directly to the monolayer in 35 mm dishes.
Samples were collected and boiled for 5 min. Proteins were separated
by SDS^PAGE (10%) and transferred to nitrocellulose membranes.
Blots were blocked for 1 h in Tris-bu¡ered saline (TBS) containing
0.1% (v/v) Tween-20 and 5% skim milk powder (Carnation). Blots
were then incubated with primary antibody overnight at 4‡C, at
1:1:000 dilution in primary antibody dilution bu¡er (5% bovine se-
rum albumin, TBS, 0.1% Tween-20). Rabbit anti-PKB-ser473 and rab-
bit phospho-GSK-3K/L (Ser21/9) antibodies were obtained from NEB.
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Horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary
antibodies were used at 1:2000 dilution. The PhotoTope-HRP detec-
tion system (NEB) was used according to the manufacturer’s direc-
tions.
3. Results
3.1. Lys527 and Lys530 are essential for full
phosphatidylinositol phosphatase activity of SigD
In addition to two motifs bearing homology to mammalian
inositol 4-phosphatases, SigD contains a region of homology
to the inositol 5-phosphatase synaptojanin (Fig. 1B). This
region is near the carboxyl-terminus of SigD (residues 507^
563) and within a domain of synaptojanin similar to other
type II inositol 5-phosphatases (residues 495^550). This
prompted us to investigate the substrate preferences of
SigD. Recombinant SigD was incubated with a number of
short chain phosphatidylinositol lipids. Activity of SigD to-
wards the various substrates was assessed in a colorimetric
assay that measures phosphate release (Fig. 2A). Of the
monophosphorylated inositol phospholipids, the wild type
protein showed signi¢cant activity towards PtdIns(4)P and
PtdIns(5)P, but not PtdIns(3)P. Of the inositol phospholipids
with multiple phosphate moieties, SigD showed the greatest
activity towards PtdIns(3,4,5)P3 and phosphatidylinositol 3,5-
biphosphate (PtdIns(3,5)P2), followed by PtdIns(3,4)P2 and
Fig. 1. Cellular functions of SigD and homology to synaptojanin. A: The SPI1 TTSS injects e¡ectors into the host cell to activate multiple sig-
naling pathways, some of which result in membrane ru¥ing and bacterial uptake. For example, SopE catalyzes exchange of GDP for GTP on
Rac1 and Ccd42 [4], thus activating them and inducing membrane ru¥ing. SigD converts Ins(1,3,4,5,6)P5 into Ins(1,4,5,6)P4, which can indi-
rectly activate Cdc42 [15]. Ins(1,4,5,6)P4 may also be responsible for the increased £uid secretion and recruitment of subepithelial neutrophils in
a ligated bovine intestinal loop model of diarrhea [17,24]. PI3K is activated by an unknown bacterial e¡ector(s), thought to induce the recruit-
ment of Akt to PtdIns(3,4,5)P3 at membrane ru¥es. The mechanism through which SigD induces the phosphorylation and activation of Akt is
unknown, prompting us to investigate the inositol phospholipid substrate preferences of SigD. B: Partial sequence alignment of SigD and rat
synaptojanin. Identical residues are shaded in black, and similar residues are shaded in gray. Asterisks indicate residues mutated in SigD in this
study. Sequences were aligned with Clustal W and shaded with Boxshade through the Biology Workbench 3.2 server (http://workbench.sdsc.
edu/CGI/BW.cgi).
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PtdIns(4,5)P2. As expected, changing Cys462 within the sec-
ond 4-phosphatase motif to a serine residue completely abro-
gated activity, since this is considered to be a critical catalytic
residue ([14,21] and Fig. 2A). To determine the functional
relevance of the homology between SigD and synaptojanin,
two conserved lysine residues were changed to alanine (Fig.
1B, marked with *). Altering Lys527 and Lys530 signi¢cantly
reduced the phosphatase activity of SigD (Fig. 2A). Kinetic
analysis of the reaction shows that phosphate release by wild
type SigD increased sharply within the ¢rst 5 min and pla-
teaued by 10^20 min (Fig. 2B). The Lys530 mutant had essen-
tially no activity, while the Lys527 mutant had an intermedi-
ate level of activity (Fig. 2B).
3.2. Reduced phosphatase activity of Lys527 and Lys530 SigD
mutants correlates with reduced activation of Akt in vivo
We wished to determine whether the reduced phosphatase
activity of the SigD mutants correlated with a reduced ability
to activate Akt in vivo. To further assess the importance of
residues in the area of homology to synaptojanin, additional
residues were individually mutated (Fig. 1B, marked with *).
A conserved valine (Val528), a conserved leucine (Leu508)
and a non-conserved leucine (Leu539) were each changed to
alanine. Mutations were incorporated into wild type sigD in
pACYC184 (designated pACDE), and used to complement S.
typhimurium devoid of SigD (vsigD). HeLa cells were serum-
starved for 3 h and then infected with either wild type S.
typhimurium (strain SL1344) or the vsigD strain carrying
pACDE or derivatives with the indicated mutations. After
infection, the cells were lysed, and the phosphorylation state
of Akt was assessed by probing Western blots with phospho-
speci¢c antibodies recognizing Ser473 or Thr308 phosphory-
lation (Fig. 3A,B). As we have previously reported [14], mu-
tation of the critical catalytic cysteine residue (C462S)
abrogated SigD activation of Akt. When Lys527 was mutated,
the activation of Akt was signi¢cantly reduced, with phos-
phorylation at Thr308 barely detectable. Mutation of
Lys530, however, completely abrogated the phosphorylation
and activation of Akt by SigD. Altering the other residues,
Leu508, Val528, and L539, had no e¡ect on Akt activation
compared to wild type SigD. The expression level and com-
petence for secretion of the point mutants were also assessed.
When S. typhimurium SL1344 is grown under conditions
which induce secretion of SPI1 TTSS, SigD is visible on a
Coomassie-stained gel among other proteins secreted into
the growth medium [22]. The SigD point mutants were all
secreted by the SPI1 TTSS in amounts comparable to the
wild type protein (Fig. 3C), indicating these mutant proteins
are still synthesized and exported by the TTSS.
3.3. S. £exneri IpgD is also an inositol phosphatase
IpgD is 59% similar and 41% identical to SigD/SopB, at the
amino acid level. It has been shown to be secreted by the
TTSS of S. £exneri and is involved in the modulation of the
Fig. 2. Phosphoinositide phosphatase activity of SigD and SigD
point mutants. Recombinant puri¢ed protein was incubated with
phosphoinositides and release of phosphate was detected colorimet-
rically by absorbance at 620 nm. A: Substrate preference pro¢le of
wild type SigD (WT) and SigD point mutants. Proteins (80 ng)
were incubated with substrate phosphoinositides (50 WM) for 20 min
at 37‡C. Phosphatidylinositol (PI) was used as a background control
incubation and gave the same values as incubations of protein with-
out any lipid (data not shown). Data are represented as mean þ S.D.
of at least three separate experiments. B: Time course of phosphate
release. PtdIns(3,4,5)P3 (100 Wg) was incubated with SigD wild type
and mutant proteins and the reaction stopped at indicated times.
Data are shown as mean values (n = 3), the standard deviations are
within the symbol size.
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host’s cytoskeletal response upon bacterial entry [23]. IpgD,
when expressed alone, is unstable in bacteria ([23] and our
unpublished results). Therefore, IpgD was puri¢ed together
with its chaperone IpgE and used in a substrate preference
assay. SigD, when puri¢ed together with its chaperone SigE,
had a similar substrate preference pro¢le to SigD alone (data
not shown). The substrate preference of IpgD was similar to
that of SigD, however IpgD used PtdIns(3,4,5)P3 signi¢cantly
more than the other substrates (Fig. 4A). As expected, a mu-
tation at Cys439, which is the critical catalytic cysteine resi-
due, completely abrogated IpgD phosphatase activity.
3.4. Activation of Akt by IpgD requires Lys507
To determine whether IpgD is also able to activate Akt,
ipgD and ipgE were cloned into pACYC184 under the tran-
scriptional control of the sigD promoter and introduced into
the vsigD strain. As before, HeLa cells were infected with
bacteria and the phosphorylation state of Ser473 of Akt was
determined (Fig. 4B, upper two panels). To assess Akt enzy-
matic activity, total Akt was immunoprecipitated from cell
extracts using an immobilized antibody that recognizes both
phosphorylated and non-phosphorylated forms. Immunopre-
cipitates were then incubated with a recombinant protein con-
taining the consensus sequence surrounding Ser21 of GSK-3K
or Ser9 of GSK-3L, which are Akt substrates, and ATP. The
products were analyzed by Western blotting with an antibody
speci¢cally detecting phospho-GSK-3 (Fig. 4B, lower panel).
Wild type IpgD (pACipgDE) induced both the phosphoryla-
tion of Akt at Ser473 and activation of Akt. As expected,
mutating the conserved catalytic cysteine residue (C439S) ab-
rogated this activity (pACipgDE*). Mutating IpgD Lys507,
analogous to Lys530 of SigD, also abrogated phosphorylation
and activation of Akt (Fig. 4C). Therefore, this conserved
lysine residue is functionally conserved between these two bac-
terial species.
4. Discussion
Our previous study demonstrated that the S. typhimurium
SPI1 TTSS translocated e¡ector SigD induces Akt activation,
the ¢rst bacterial e¡ector identi¢ed to activate this signaling
pathway [14]. Intriguingly, both wild type S. typhimurium and
the vsigD strain stimulate both translocation of Akt to mem-
brane ru¥es and the association of PI3K with phosphotyro-
sine-containing proteins [14]. Therefore, another bacterial ef-
fector must be responsible for the initial activation of PI3K
upstream of the action of SigD.
Recent reports have shown that in vivo, SigD/SopB
functions speci¢cally as a 3-phosphatase to convert Ins-
(1,3,4,5,6)P5 into Ins(1,4,5,6)P4 [15,16]. SopB, the nearly
identical SigD homologue of Salmonella dublin, is required
for both increased £uid secretion and recruitment of subepi-
thelial neutrophils in a ligated bovine intestinal loop model of
diarrhea [17,24]. This activity is attributed to an increase in
intracellular Ins(1,4,5,6)P4, a product of the inositol phospha-
tase activity of SopB in S. dublin-infected T84 colonic epithe-
lial cells [25] (Fig. 1A). Ins(1,4,5,6)P4 produced by SigD has
also been proposed to act in concert with SopE to activate
Rho GTPases, promoting host cell actin cytoskeleton rear-
rangements and bacterial internalization [15]. We have ex-
tended previous observations that SigD can hydrolyze inositol
phospholipids [17] by testing a wider range of lipid substrates.
Of the monophosphorylated inositol phospholipids, SigD had
the greatest activity towards PtdIns(5)P, while PtdIns(3)P was
not a substrate. Of the inositol phospholipids with multiple
phosphate moieties, PtdIns(3,5)P2 and PtdIns(3,4,5)P3 were
the best substrates. IpgD also hydrolyzed phosphate groups
from inositol phospholipids, and preferred substrates in the
order PtdIns(3,4,5)P3sPtdIns(3,4)P2sPtdIns(3,5)P2. Taken
together, these results suggest that both SigD and IpgD are
capable of hydrolyzing phosphate groups from the 5P position
of lipid substrates, including PtdIns(3,4,5)P3. We have found
that Lys527 and Lys530 in SigD are absolutely required for
full inositol phosphatase activity. Moreover, the activity level
Fig. 3. Lys527 and Lys530 of SigD are essential for full Akt activa-
tion. A and B: Cells were incubated with either wild type S. typhi-
murium (SL1344) or the vsigD strain carrying control plasmid pA-
CYC184 (3), plasmids encoding wild type SigD (pACDE) or the
indicated point mutations for 25 min. Western blot analysis was
with phosphospeci¢c antibodies (upper panels) to Ser473 (A) or
Thr308 (B), after which the blots were stripped and probed with
anti-Akt to detect total Akt (lower panels). C: The SigD point mu-
tants are synthesized and secreted by Salmonella in amounts compa-
rable to the wild type protein. The S. typhimurium strains from B
and C were grown under conditions that induce the secretion of
SPI1 proteins into the culture media [22]. Proteins were precipitated
with trichloroacetic acid and separated by SDS^PAGE. The gel was
subsequently stained with Coomassie R-250.
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of these mutants in vitro correlates with Akt activation in
vivo. These residues lie within a region of homology to the
mammalian 5-phosphatase synaptojanin, in a region that is
similar to other type II 5-phosphatases. These observations
suggest that this domain of SigD and synaptojanin is impor-
tant for substrate recognition and/or catalysis.
We demonstrated that S. £exneri IpgD activates Akt in
epithelial cells when translocated by Salmonella, a previously
uncharacterized activity of this protein. Moreover, a mutant
in IpgD at Lys507, analogous to SigD Lys530, completely
abrogates Akt activation, and presumably phosphatase activ-
ity. However, it is not known if S. £exneri activates Akt upon
invasion. An increase in intracellular Ins(1,4,5,6)P4 is not ob-
served in S. £exneri-infected T84 colonic epithelial cells, as it
is in S. dublin-infected cells [25]. Thus, whereas previous stud-
ies do not show a similar function of IpgD and SopB/SigD,
we demonstrate that these two proteins do indeed have similar
activities.
We propose a two-step mechanism for how Akt might be
activated by Salmonella. The SPI1 TTSS of Salmonella injects
e¡ectors that promote membrane ru¥ing, bacterial uptake,
and the activation of PI3K. The subsequent increased concen-
tration of PtdIns(3,4,5)P3 at membrane ru¥es results in re-
cruitment of Akt, and its activating kinase(s). We have pre-
viously shown Akt recruitment to be a SigD-independent
process. We propose that the 5P phosphatase activity of
SigD converts PtdIns(3,4,5)P3 into PtdIns(3,4)P2, inducing a
conformational change in recruited Akt, favoring its phos-
phorylation at Thr308 and Ser473 and allowing full activa-
tion. The relative contribution of PtdIns(3,4,5)P3 versus
PtdIns(3,4)P2 to Akt activation is controversial [8,26], and
may be related to cell type and the local environment. Indeed,
there is evidence that PtdIns(3,4)P2 is required for Akt acti-
vation in mast cells (V. Duronio, personal communication).
Membrane recruitment of Akt is very localized in this system,
occurring only at membrane ru¥es in the vicinity of bacteria.
Upon stimulation by growth factors, for example, membrane
recruitment of Akt occurs over the whole cell surface. This
would explain why overexpression of SigD/SopB does not
result in measurable di¡erences in cellular inositol lipids
[16]. We believe that the changes in PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 levels may be too small and localized to detect,
relative to the abundant PtdIns(4,5)P2 in membranes.
Our study reveals a previously unrecognized homologous
Fig. 4. S. £exneri IpgD hydrolyzes inositol phospholipids and acti-
vates Akt. A: S. £exneri wild type IpgD and mutant proteins (200
ng) were incubated with substrate phosphoinositides (150 WM) for
1 h at 37‡C (n = 3). B: Activation of Akt by IpgD. Cells were infected
with S. typhimurium as described in Fig. 3. Plasmids expressing
ipgD and its chaperone ipgE (pACipgDE) or the C439S mutant
(pACipgDE*) were introduced into the vsigD strain and tested in
parallel with SL1344. Western blot analysis was performed as de-
scribed in Fig. 3 (upper two panels). Bottom panel: cell extracts
were incubated with immobilized antibody recognizing both phos-
phorylated and non-phosphorylated forms of Akt. Antibody beads
were washed extensively and resuspended in kinase bu¡er supple-
mented with 200 WM ATP and 1 Wg GSK-3 fusion protein. Western
blotting was with phosphospeci¢c antibodies to GSK-3K/L (Ser21/9).
C: Mutation of Lys507 abrogates Akt activation. vsigD strains
transformed with either control pMW119 (3) or pMW119 contain-
ing wild type ipgD and ipgE (pMWipgDE), or an ipgD point mu-
tant (pMWipgDE-K507E) were incubated with HeLa cells as de-
scribed. Western blotting was as described in Fig. 3.
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domain of SigD and synaptojanin. That this important region
of both SigD and IpgD lies within the type II 5-phosphatase
domain of synaptojanin supports our model for Akt activa-
tion by Salmonella. It also suggests that these residues play an
important role in the recognition or hydrolysis of the 5P phos-
phate moiety of inositol lipid substrates used by both phos-
phatases.
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